BARCOV: "Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"

Sponsor
Sultan Qaboos University (Other)
Overall Status
Completed
CT.gov ID
NCT05216523
Collaborator
(none)
251
1
5.2
48

Study Details

Study Description

Brief Summary

A retrospective study is planned to find out the incidence and association type of respiratory support with barotrauma in Covid-19 cases admitted in Sultan Qaboos University Hospital. As widely known, Covid-19 affects the respiratory system primarily and is the main cause of admission to hospital. Depending upon the severity, different levels of respiratory support are offered to the patients. Normally patients with viral/bacterial respiratory diseases have a low incidence of barotrauma. Since this disease is new and it has been observed that a significant number of covid-19 patients develop barotrauma, hence it is deemed worthwhile to investigate the matter.

All the patients admitted to the ward, high dependency unit, and intensive care unit will be scanned and those who developed barotrauma (pneumothorax, surgical emphysema, pneumo-pericardium, and pneumo-mediastinum) will be studied in detail and analyzed.

This review is expected to highlight the problem and etiology and we might be able to suggest a management strategy to deal with this problem.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Introduction

    Covid-19 is a recently emerged disease affecting the respiratory system primarily but later on, progresses to multisystem involvement. Most of the cases are mild and self-remitting. However, those who develop moderate to severe symptoms require admission. They receive different modalities of respiratory support as per the international guidelines.

    The covid-19 typically starts with mild respiratory symptoms with fever, headache, and myalgia. Most of the cases remit after these by 10 days, but around 15% progress to more severe symptoms such as worsening of fever, respiratory symptoms leading to hypoxemia proceeding to complications further on. Correspondingly, the radiological findings peak by 2 weeks after symptom onset. By this point in time, the patients start requiring respiratory support and complications start to emerge as the time passes. Bacterial superinfections, interleukin surge, septic shock are commonly encountered. Recently, at our center rising episodes of barotrauma have been observed.

    In the covid era because of huge numbers of admissions, the hospital, as well as ICU beds with respiratory and monitoring resources, are becoming significantly scarce (4). Hence prevention of complications can have a great impact on improving patient outcomes and utilizing hospital resources.

    There can be few recognized mechanisms of barotrauma in Covid-19 cases. One of them is alveolar overdistension leading to rupture and barotrauma and the second is a decrease in the caliber of pulmonary vessels increasing pressure gradient causing air leak to the sheath. Positive pressure ventilation leads to an increase in intra-alveolar alveoli. Macklin phenomenon also describes the occurrence of a large pressure gradient between marginal alveoli and lung interstitium leading to barotrauma (5).

    Barotrauma is treated by intercostal drain insertion, as well as conservative management by the reduction in airway pressures and increase in oxygen supplementation. Both these can lead to setbacks in a patient's recovery.

    This research will identify the etiology of barotrauma and will highlight the preventive strategy to deal with it.

    Aim of the Study:

    This study aims to examine the incidence of barotrauma, its association with different management strategies so as to suggest modification of preventive and inciting factors. This may improve patient outcomes and conserve hospital resources.

    Specific objectives:
    1. To study the incidence of barotrauma in hospitalized Covid-19 cases.

    2. To find the association of factors inciting barotrauma.

    3. To formulate a management plan for the prevention of barotrauma in these cases.

    Methodology and study design:

    This retrospective study will be conducted in the Department of Anesthesia and ICU at Sultan Qaboos University hospital (SQUH) situated in Muscat, Oman. All admitted patients of Covid-19/SARS-2 between March 2020 to April 2021 will be scanned in the computerized system with the keywords: barotrauma, pneumothorax, surgical emphysema, pneumo-pericardium, and pneumo-mediastinum. A list of cases with these problems will be obtained and the cases will be studied in detail. Data will be obtained from SQUH "Track Care" hospital information system.

    Study Population:
    Inclusions:

    ● All admitted patients of Covid-19/SARS-2 between March 2020 to April 2021 t SQUH

    Exclusions:

    ● Patients who develop barotrauma due to central line insertion or trauma prior to admission.

    Data Collection and Analyses:

    Demographic details, Day of barotrauma, comorbidities, type of respiratory support, other treatment modalities, and covid laboratory profile: ferritin, LDH, CRP, IL-6, fibrinogen, white cell count, and lymphocyte counts.

    SPSS software (version 23) will be used to collect and analyze data. Obtaining the significance of association will be through using students' t-test, fisher's exact test, and Chi-square test. P-value < 0.05 will be considered significant.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    251 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    "Review of Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study From March 2020 Till April 2021."
    Actual Study Start Date :
    Jun 24, 2021
    Actual Primary Completion Date :
    Nov 30, 2021
    Actual Study Completion Date :
    Nov 30, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Cases

    Admitted Covid-19 cases who developed Barotrauma

    Controls

    Admitted Covid-19 cases who did not develop Barotrauma, matched with Cases with respect to age and sex.

    Outcome Measures

    Primary Outcome Measures

    1. Incidence of Barotrauma in admitted Covid-19 cases [1-102 days]

      Incidence of Barotrauma in admitted Covid-19 cases between March 2020 till April 2021

    Secondary Outcome Measures

    1. Association of factors with Barotrauma in admitted Covid-19 cases [1-102 days]

      Association of factors with Barotrauma in admitted Covid-19 cases

    2. Mortality with cases versus controls [1-102 days]

      Mortality with cases versus controls

    3. Ventilation days of cases versus controls [1-65 days]

      Ventilation days

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 89 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All admitted adult patients with covid PCR positive result

    • Those who developed barotrauma were labeled as "Cases" and those without barotrauma were "Controls".

    Exclusion Criteria:
    • Adult patients with covid PCR positive result who were discharged from Emergency department.

    • Adult patients with covid PCR positive result who died or left against medical advice before admission to ward/ICU

    • Adult patients with covid PCR positive result who were shifted to other hospitals and their follow up could not be completed.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sultan Qaboos University Hospital Muscat Oman 123

    Sponsors and Collaborators

    • Sultan Qaboos University

    Investigators

    • Study Director: Jyoti Burad, Sultan Qaboos University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr Jyoti Barud, Senior specialist, Sultan Qaboos University
    ClinicalTrials.gov Identifier:
    NCT05216523
    Other Study ID Numbers:
    • #2463
    First Posted:
    Jan 31, 2022
    Last Update Posted:
    Jan 31, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dr Jyoti Barud, Senior specialist, Sultan Qaboos University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 31, 2022